Phase 3 EPCORE DLBCL-2 shows how partnerships can compound value
Two Medicare Pricing Shocks Land on Pharma Within 48 Hours
With GLOBE now finalized and drug tariffs already live, the fight over which rule hits 2027 earnings harder is just…
WEC Energy’s Nuclear Deal Shows Utilities Can Grow
Oracle absorbing $300 million in Point Beach fuel costs is proof regulated utilities are no longer just income plays.
Nvidia Nears $5.7 Trillion. The Q3 Report in 45 Days Matters.
A $150 billion buyback and a $108 billion Q3 guide pushed shares to a record. The forward multiple is near…
Nike Fell 9% After Earnings. Where the Turnaround Stands
China revenue dropped 26%, FY27 EPS guidance missed badly, and shares are near a 52-week low. Is the pain already…
onsemi Paid $1.3 Billion Less for Synaptics. That’s the Point.
The revised deal shifts to cash, adds earnings on day one, and a rival bid confirms what these assets are…
121 Billion Extra Gallons of Gasoline, 26 Plaintiffs Suing
DOT's CAFE rollback cuts automaker costs while weakening the policy support for EV investment.
Moderna Is Up About 500% in 2026. Oct. 24 Could Double It or Erase the Rally.
Full Phase 3 melanoma data arrives at ESMO on Oct. 24. Investors have priced a conclusion without seeing the curves.
Every Jobs Number This Morning Leads to a Different Fed
The September payrolls report decides whether the 10-year’s 24-year high holds or breaks, and which sectors you want to own…
Transformer Lead Times Are 3 Years. The Winners Have Contracts.
GE Vernova, Eaton, and Siemens Energy are locking in supply. Backlog math is the tell.
